Kalaris (KLRS) PT Lowered to $25 at Citizens Ahead of Phase 1b/2 MAD data in 2027
Citizens analyst Jonathan Wolleben lowered the price target on Kalaris (NASDAQ: KLRS) to $25.00 (from $26.00) while maintaining a Market ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
